HOME >> MEDICINE >> NEWS
American Heart Association Comment: Results Of Cardiac Insufficiency Bisoprolol Study II (CIBIS-II)

People with mild to moderate heart failure who were treated with beta-blockers were more likely to survive than individuals who did not receive the drugs, according to a study, CIBIS-II, published in the Jan. 2 issue of Lancet.

Harlan Krumholz, M.D., an American Heart Association spokesperson, who wrote an editorial that accompanied the study, says, "The CIBIS-II trial is an important turning point. Small studies have been accumulating suggesting the value of beta-blockers for patients with heart failure, but this trial provides the first real convincing evidence that patients with mild or moderate heart failure live longer and have less need for hospitalization when treated with beta blockers. Disseminating information about this trial will provide an important public service. We need to get this information to physicians and patients."

In the beta-blocker group there were 34 percent fewer deaths from all causes, and 44 percent fewer sudden deaths. Hospital admissions were 20 percent less among those who received the beta-blocker.

The results of the study suggest that physicians should be using beta-blockers to treat stable patients (someone whose condition is not worsening) with mild to moderate heart failure, first with low doses that should be gradually increased, says Krumholz, associate professor of medicine, Yale School of Medicine.

"The drugs are inexpensive and the benefits are substantial. The message is that we should be looking for opportunities to use these drugs rather than avoid them." Beta-blockers have not been routine drugs for heart failure due to their "depressive" effects on the heart. However, new information about the mechanism of heart failure has led scientists to re-consider the drugs because they may help block the action of some hormones that are released when the heart is damaged.

"These are the same hormones that are released during the 'fight or flight' response and may cause more damage to a weakened h
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
31-Dec-1998


Page: 1 2

Related medicine news :

1. Consumers with disabilities empowered by American Disabilities Act
2. Definition of persistent vegetative state available from American Academy of Neurology
3. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
4. New colorectal cancer screening recommendations for African Americans
5. American Thoracic Society Journal news tips for March 2005 (second issue)
6. Community care tops medical care at preventing heart disease in black Americans
7. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
8. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
9. Awards & fellowships at the International & American Association for Dental Research General Session
10. American Academy of Neurology presents 57th Annual Meeting in Miami Beach
11. News tips from the 2005, 54th Annual Scientific Sessions of the American College of Cardiology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... January 10, 2020 , ... WellHaven Pet Health, a ... in a new online community coming in February 2020, LEAD WELL with WOMEN. The ... Wellbeing Village. , The vision of LEAD WELL with WOMEN is to empower women, ...
(Date:1/10/2020)... ... January 10, 2020 , ... SMG3Rx, a clinical ... be attending the HIMSS (Healthcare Information and Management Systems Society) Global Conference & ... health information and technology event of the year, where professionals throughout the global ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... sciences teams, announced today that the company is rebranding as Red Nucleus R&D, ... and performance solutions for the life sciences industry. , The addition of ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real ... Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... (RWD) to generate evidence and identify gaps and challenges when conducting trials? The ...
(Date:1/7/2020)... ... January 07, 2020 , ... G-CON Manufacturing, ... to the company’s 200,000 sq. ft. manufacturing site in College Station, TX. The ... dedicated to POD architectural, mechanical, electrical and automation fit out. , “This facility ...
Breaking Medicine News(10 mins):
(Date:1/8/2020)... Mich. (PRWEB) , ... January 08, 2020 , ... ... leader in FDA compliance consulting, is proud to announce the attainment of a ... Council, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC). ...
(Date:1/8/2020)... ... January 09, 2020 , ... ... partner practices a complimentary freezer program. The cryogenic freezer allows practices to have ... top stem cell and exosome biologics require cryogenic freezing. This may include a ...
(Date:1/7/2020)... ... 2020 , ... Myant Inc., the pioneers in Textile Computing™, will be showcasing ... CES 2020 (January 7-10, Las Vegas), including apparel from the Skiin Connected Health & ... of the CES 2020 Innovation Awards. , While electrocardiography, or the study of the ...
Breaking Medicine Technology:
Cached News: